Play Earnings CallPlay Earnings Call
Protalix BioTherapeutics, Inc. (PLX) Q1 2026 Earnings Call May 13, 2026 8:00 AM EDT
Company Participants
Dror Bashan – President, CEO & Director
Gilad Mamlok – Senior VP, CFO Treasurer & Secretary
Conference Call Participants
Mike Moyer – Lifesci Advisors, LLC
Raghuram Selvaraju – H.C. Wainwright & Co, LLC, Research Division
John Vandermosten – Zacks Small-Cap Research
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics First Quarter 2026 Financial and Business Results Conference Call. As a reminder, this conference is being recorded.
I will now turn the conference over to our host, Mr. Mike Moyer of LifeSci Advisors, Investor Relations for Protalix. Thank you. Please go ahead.
Mike Moyer
Lifesci Advisors, LLC
Thank you, operator, and welcome to the Protalix BioTherapeutics Q1 2026 Financial Results and Business Update Conference Call. With me today are Dror Bashan, President and CEO of Protalix; and Gilad Mamlok, Senior Vice President and Chief Financial Officer.
A press release announcing the financial results and corporate updates were issued this morning and are available now on the Protalix website. Please take a moment to read the disclaimer about forward-looking statements in the press release. The earnings release and this teleconference include forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from the statements made. Factors that could cause actual results to differ are described in the disclaimer and in Protalix’s filings with the U.S. Securities and Exchange Commission.
I will now turn the call over to Mr. Bashan. Dror?
Dror Bashan
President, CEO & Director
Thank you, Mike, and thank you, everyone, for joining our Q1 2026 financial results and business update call. I want to begin by highlighting 2 points that underscore the strength of our business today. First, during the quarter, we received a $25 million
